Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...
Cantech Letter

Antimony Stocks and the Global Battle for Critical Minerals

Critical Mineral Company Locksley Resources Limited Advances Towards U.S. Antimony Production Vancouver, Kelowna, and Delta, British Columbia–(Newsfile Corp. – November 13, 2025) – Investorideas.
Le Lézard

BlackRock Survey Reveals Surge of First-Time ETF Investors, Driven by Equity and Digital Asset Demand

BlackRock today released its inaugural U.S. "People & Money" report focused on the next wave of exchange traded fund (ETF) investors, revealing a powerful shift in how Americans are engaging with ...
BMJ Open

What are the barriers and facilitators to the acceptance of information and communication technology-based interventions for improving resilience and mental health of ...

Introduction Healthcare workers (HCWs) report overwhelming demands and experience crisis levels of burnout and unique challenges that further impair their mental health. Promotion of mental health ...
BMJ Open

Maximising the potential of the National Compulsory Service Programme in rural China: a mixed methods study

Objectives To alleviate the shortage of qualified physicians in rural areas, since 2010, the Chinese government has launched a National Compulsory Service Programme (NCSP) to enrol medical students ...

LiqTech International, Inc.: LiqTech International Announces Third Quarter 2025 Financial Results

LiqTech International, Inc. (Nasdaq: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies ...